SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease.
作者信息
Trujillo Hernando, Caravaca-Fontán Fernando, Sevillano Ángel, Gutiérrez Eduardo, Caro Jara, Gutiérrez Elena, Yuste Claudia, Andrés Amado, Praga Manuel
机构信息
Department of Nephrology, University Hospital "12 de Octubre", Madrid, Spain.
Investigation Institute of University Hospital "12 de Octubre" (imas12), Madrid, Spain.
出版信息
Kidney Int Rep. 2020 May 1;5(6):905-909. doi: 10.1016/j.ekir.2020.04.024. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease.肾病住院患者的新型冠状病毒2型感染
Kidney Int Rep. 2020 May 1;5(6):905-909. doi: 10.1016/j.ekir.2020.04.024. eCollection 2020 Jun.
2
Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.新型冠状病毒病 19 感染不会导致急性肾损伤：来自中国武汉的 116 例住院患者分析。
Am J Nephrol. 2020;51(5):343-348. doi: 10.1159/000507471. Epub 2020 Mar 31.
3
Analysis of the impact of the SARS-CoV-2 infection on the pediatric population hospitalized during the pandemic in the Greater Paris University Hospitals.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对大巴黎大学医院疫情期间住院儿童人群影响的分析。
Front Pediatr. 2023 Feb 27;11:1044352. doi: 10.3389/fped.2023.1044352. eCollection 2023.
4
SARS-CoV-2 infection in kidney transplant recipients: clinical impact and outcomes - a single center experience.肾移植受者中 SARS-CoV-2 感染：临床影响和结局-单中心经验。
J Bras Nefrol. 2022 Jul-Sep;44(3):376-382. doi: 10.1590/2175-8239-JBN-2021-0164.
5
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.SARS-CoV-2 感染后 2 年住院与非住院患者的新冠后症状。
JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.
6
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群：一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination.感染和接种后对 SARS-CoV-2 的异源中和活性。
Front Immunol. 2022 May 30;13:888794. doi: 10.3389/fimmu.2022.888794. eCollection 2022.
9
Hamster organotypic kidney culture model of early-stage SARS-CoV-2 infection highlights a two-step renal susceptibility.早期SARS-CoV-2感染的仓鼠器官型肾脏培养模型突出了肾脏易感性的两个阶段。
J Tissue Eng. 2022 Sep 6;13:20417314221122130. doi: 10.1177/20417314221122130. eCollection 2022 Jan-Dec.
10
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium).严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对因急性心脏疾病住院患者预后的影响。一项前瞻性多中心队列研究（瑞士心血管SARS-CoV-2联盟）。
Front Cardiovasc Med. 2023 Oct 13;10:1203427. doi: 10.3389/fcvm.2023.1203427. eCollection 2023.
引用本文的文献
1
THE EFFECT OF URIC ACID LEVEL ON THE SEVERITY OF COVID-19.尿酸水平对新型冠状病毒肺炎严重程度的影响
Acta Clin Croat. 2024 Oct;63(2):251-259. doi: 10.20471/acc.2024.63.02.1.
2
Eosinopenia as a prognostic factor of mortality for COVID-19 in end-stage kidney disease patients.嗜酸性粒细胞减少作为终末期肾病患者新冠病毒病死亡的预后因素
Caspian J Intern Med. 2024 Spring;15(2):273-279. doi: 10.22088/cjim.15.2.273.
3
Evaluation of hemodialysis patients and hemodialysis health workers with COVID-19 IgM and IgG antibody test; a multicenter study from Eskisehir, Turkiye.采用新冠病毒 IgM 和 IgG 抗体检测评估血液透析患者及血液透析医护人员；来自土耳其埃斯基谢希尔的一项多中心研究。
North Clin Istanb. 2022 Oct 27;9(5):476-783. doi: 10.14744/nci.2021.62447. eCollection 2022.
4
Pericarditis secondary to COVID-19 infection in a kidney transplant recipient.一名肾移植受者继发于新型冠状病毒肺炎感染的心包炎
Nefrologia (Engl Ed). 2021 May-Jun;41(3):349-351. doi: 10.1016/j.nefroe.2021.07.003. Epub 2021 Jul 23.
5
Covid-19 in Egyptian hemodialysis and kidney transplant children: retrospective analysis of single center experience.埃及血液透析和肾移植儿童中的 COVID-19：单中心经验回顾性分析。
Ital J Pediatr. 2022 Aug 19;48(1):149. doi: 10.1186/s13052-022-01345-z.
6
Single-center Haemodialysis Experience in India During COVID-19.印度在2019冠状病毒病期间的单中心血液透析经验
Indian J Nephrol. 2022 Mar-Apr;32(2):110-115. doi: 10.4103/ijn.IJN_230_20. Epub 2022 Jan 5.
7
First Wave of COVID-19 Pandemic in Italy: Data and Evidence.意大利的 COVID-19 大流行第一波：数据和证据。
Adv Exp Med Biol. 2021;1353:91-113. doi: 10.1007/978-3-030-85113-2_6.
8
Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis.新冠病毒肺炎肾移植患者的死亡风险因素：一项系统综述与回归分析
Health Sci Rep. 2021 Nov 4;4(4):e427. doi: 10.1002/hsr2.427. eCollection 2021 Dec.
9
The Impact of COVID-19 on Kidney Transplant Recipients in Pre-Vaccination and Delta Strain Era: A Systematic Review and Meta-Analysis.新冠疫情对疫苗接种前及德尔塔毒株时代肾移植受者的影响：一项系统评价与荟萃分析
J Clin Med. 2021 Sep 30;10(19):4533. doi: 10.3390/jcm10194533.
10
Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis.新冠病毒肺炎血液透析患者死亡的危险因素：一项系统评价与荟萃分析
Ren Fail. 2021 Dec;43(1):1394-1407. doi: 10.1080/0886022X.2021.1986408.
本文引用的文献
1
COVID-19 in Hemodialysis Patients: A Report of 5 Cases.COVID-19 于血液透析患者：五例报告。
Am J Kidney Dis. 2020 Jul;76(1):141-143. doi: 10.1053/j.ajkd.2020.03.009. Epub 2020 Mar 31.
2
Likelihood of survival of coronavirus disease 2019.2019冠状病毒病的生存可能性。
Lancet Infect Dis. 2020 Jun;20(6):630-631. doi: 10.1016/S1473-3099(20)30257-7. Epub 2020 Mar 30.
3
COVID-19 in kidney transplant recipients.肾移植受者中的新型冠状病毒肺炎
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
4
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?COVID-19 于肾移植受者中的病例报告：免疫抑制是否改变临床特征？
Am J Transplant. 2020 Jul;20(7):1875-1878. doi: 10.1111/ajt.15874. Epub 2020 Apr 9.
5
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.肾移植受者长期免疫抑制后 COVID-19 肺炎的成功康复。
Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Zotero 插件